| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002186 | 全聚德 | 12.28 | 3.37% | 11.24万 | 1.36 Z | | 601007 | 金陵饭店 | 8.22 | 2.11% | 11.96万 | 9722.68万 | | 000428 | 华天酒店 | 3.55 | 2.01% | 23.22万 | 8179.43万 | | 000721 | 西安饮食 | 9.37 | 1.30% | 1 22.99万 | 2.14亿 | | 301073 | 君亭酒店 | 30.92 | 1.28% | 5.93万 | 1.83亿 | | 605108 | 同庆楼 | 19.66 | 1.08% | 3.47万 | 6776.12万 | | 600754 | 锦江酒店 | 26.79 | 0.94% | 7.89万 | 2.10亿 | | 600258 | 首旅酒店 | 16.94 | 0.24% | 16.06万 | 2.71亿 | | 002306 | *ST云网 | 2 ...

证券之星消息，1月28日酒店餐饮板块较上一交易日下跌0.64%，*ST云网领跌。当日上证指数报收于 4151.24，上涨0.27%。深证成指报收于14342.9，上涨0.09%。酒店餐饮板块个股涨跌见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 600754 | 锦江酒店 | = 104.40万 | 0.67% | -136.44万 | -0.88% | 32.04万 | 0.21% | | 605108 | 同庆楼 | -15.08万 | -0.26% | -714.18万 | -12.32% | 729.27万 | 12.58% | | 600258 | 首旅酒店 | -30.31万 | -0.13% | -3673.74万 | -16.22% | 3704.05万 | 16.35% | | 000428 华天酒店 | | -128.32万 | -2.53% | -71.55万 | -1.41% | ...

文商旅融合，激发消费新引擎 南京夫子庙秦淮河畔，华灯初上，游客们不仅流连于"夜泊秦淮"的诗意，也在老字号餐馆、文创市集和 沉浸式剧场间穿梭驻足。苏州平江路上，摇橹船划过水巷，岸边的咖啡馆、工作室与古宅院落相映成 趣，游客每一次按下快门和消费，都是文化体验与商业活动的自然融合…… 省发展改革委立足宏观统筹与项目支撑，通过完善促进消费体制机制、实施提振消费专项行动，将文商 旅融合项目纳入省级重大项目库予以重点支持。例如，研究制订《提振消费专项行动方案贯彻落实措 施》，深化"文旅+百业""百业+文旅"，支持南京西五华里休闲文化街区等8个省级重大项目和79个省级 重点文旅产业项目建设。 针对提案建议与未来发展，省文化和旅游厅在答复中介绍了具体和生动的举措。 构建文旅深度融合发展机制。牵头制定《加快把文化旅游业培育成为支柱产业的行动计划》，推动在文 旅深度融合发展路径上实施产业空间拓展、经营主体培优、优质产品供给、消费服务扩大等六大行动。 持续用力推进"两廊两带两区"建设，努力打造全域可游魅力新空间。 打造"沉浸式"多元消费场景。"十四五"期间共发布重点项目364个，其中多数为融合发展类。推出南 京"长江之恋"、苏州" ...

Investment Rating - The report assigns an "Accumulate" rating for the industry [6]. Core Insights - The civil aviation sector is expected to see record-high passenger transport volume during the Spring Festival, with an anticipated 95 million passengers, representing a year-on-year growth of approximately 5.3% [2][5]. - The retail sector showed a slight increase in consumer spending, with a total retail sales of 45,136 billion yuan in December 2025, marking a 0.9% year-on-year growth [5]. - The report highlights the continuous rise in gold prices, with spot gold surpassing 4,800 USD per ounce, leading to increased prices for domestic gold jewelry [5]. - The report emphasizes the positive impact of travel policies on tourism and hotel sectors, suggesting a focus on companies like Atour, Huazhu Group, and Jinjiang Hotels [5][6]. Summary by Relevant Sections Civil Aviation - The report indicates that the domestic flight ticket prices have slightly increased compared to the previous year during the Spring Festival [5]. - The Civil Aviation Administration forecasts a daily average of 2.38 million passengers during the Spring Festival period [5]. Retail Sector - The total retail sales for the year 2025 reached 501,202 billion yuan, reflecting a 3.7% year-on-year increase [5]. - The report notes that the opening of the child-rearing subsidy program on January 5, 2026, will provide 3,600 yuan per child annually for children under three years old [5]. Company Announcements - China Duty Free Group announced the acquisition of DFS's travel retail business in Greater China for up to 395 million USD [5]. - Jiajiayue expects a net profit of 198 million to 228 million yuan for 2025, representing a year-on-year growth of 50.06% to 72.79% [5]. - Meikailong anticipates a net loss of 22.5 billion to 15 billion yuan for 2025, a significant decline compared to the previous year [5]. - Jinling Hotel expects a net profit of 55 million to 63.5 million yuan for 2025, indicating a growth of 65.37% to 90.93% year-on-year [5].

Group 1: Company Fundraising and Investment - Company plans to use 500 million yuan of raised funds to increase capital in its wholly-owned subsidiaries for the implementation of a DRAM investment project [1] - Zhuhai Hengqin Chip Storage Co., Ltd. will receive 30 million yuan, and Hefei Chip Storage Co., Ltd. and Xi'an Chip Storage Co., Ltd. will receive 50 million yuan and 30 million yuan respectively for the DRAM project [1] Group 2: Profit Forecasts and Turnarounds - Yiling Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan in 2025, recovering from a loss of 725 million yuan in the previous year [2] - Liard anticipates a net profit of 300 million to 380 million yuan in 2025, compared to a loss of 889 million yuan last year, driven by a new strategic cycle focusing on AI [2] - Daming City forecasts a net profit of 140 million to 165 million yuan in 2025, recovering from a loss in the previous year, aided by reduced asset impairment losses [3] - Guanghua Technology expects a net profit of 85 million to 120 million yuan in 2025, recovering from a loss of 205 million yuan last year, due to expansion in specialized chemicals and PCB sectors [3] - Boteng Co. anticipates a net profit of 80 million to 105 million yuan in 2025, recovering from a loss of 288 million yuan, supported by operational efficiency improvements [4] - Shiyida expects a net profit of 31 million to 46 million yuan in 2025, recovering from a loss of 2.34 million yuan last year, driven by business development and cost control [4] - Guochuang High-tech forecasts a net profit of 16 million to 24 million yuan in 2025, recovering from a loss of 49 million yuan, aided by improved receivables management [5][6] Group 3: Share Buybacks - Hengyi Petrochemical plans to repurchase shares with a total fund of no less than 500 million yuan and no more than 1 billion yuan, with a maximum price of 15 yuan per share [7] - Yunyi Electric plans to repurchase shares with a total fund of no less than 100 million yuan and no more than 150 million yuan, with a maximum price of 17 yuan per share [7] - Xidian Pharmaceutical intends to repurchase shares with a total fund of no less than 25 million yuan and no more than 50 million yuan, with a maximum price of 42 yuan per share [7] Group 4: Performance Highlights - Te Yi Pharmaceutical expects a net profit of 70 million to 90 million yuan in 2025, a growth of 241.55% to 339.13% year-on-year [8] - Xingqi Eye Medicine anticipates a net profit of 662 million to 749 million yuan in 2025, a growth of 95.82% to 121.56% year-on-year [8] - Tianhe Co. forecasts a net profit of 41 million to 60 million yuan in 2025, a growth of 84.35% to 169.78% year-on-year [8] - Ruichuang Micro-Nano expects a net profit of approximately 1.1 billion yuan in 2025, a 93% increase year-on-year [9] - Zhongyuan Co. anticipates a net profit of 139 million to 158 million yuan in 2025, a growth of 80% to 105% year-on-year [9] Group 5: Important Corporate Developments - Aolaide has received acceptance for its application to issue securities on the Science and Technology Innovation Board [14] - *ST Songfa's subsidiary signed contracts for the construction of two VLCC super-large oil tankers, expected to positively impact future performance [15] - Chongda Technology's subsidiary signed an investment agreement for a 1 billion yuan IC packaging project in Jiangsu Province [15] - Yinglian Co. signed a strategic agreement with LG Chem to establish a joint laboratory for innovative materials in lithium battery applications [16]

深南电A：2025年净利润同比预增584.66%-721.59% 特一药业：2025年净利润同比预增241.55%-339.13% 闰土股份：2025年净利润同比预增181.05%-227.89% 青松股份：2025年净利润同比预增137.73%-201.74% 瑞晟智能：2025年净利润同比预增112.00%-139.99% 键凯科技：2025年净利润同比预增101.09%-121.20% 兴齐眼药：2025年净利润同比预增95.82%-121.56% 睿创微纳：2025年净利润同比预增93%左右 天禾股份：2025年净利润同比预增84.35%-169.78% 中元股份：2025年净利润同比预增80%-105% 亿道信息：2025年净利润同比预增76.04%-128.85% 圣达生物：2025年净利润同比预增69.93%-120.90% 华锐精密：2025年净利润同比预增68.29%-86.99% 方正科技：2025年净利润同比预增67.06%-98.14% 金陵饭店：2025年净利润同比预增65.37%-90.93% 强一股份：2025年净利润同比预增57.87%-71.17% 朗博科技：2025年净利润 ...

（编辑 王雪儿） 证券日报网讯 1月22日，金陵饭店发布公告称，公司预计2025年度实现归属于母公司所有者的净利润为 5，500万元到6，350万元，与上年相比，将增加2，174万元到3，024万元，同比增长65.37%到 90.93%。 ...

Group 1 - Huakang Clean announced it is the first candidate for the bid of the Wuhan First Hospital expansion project with a bid amount of 54.88 million yuan and a construction period of 120 days [1] - Hualing Steel's subsidiary plans to invest 449.88 million yuan in a major overhaul project for its coking plant, aiming to address aging issues and restore production capacity over a 19-month construction period [2] - Yinjia Technology expects a net loss of 140 million to 110 million yuan for 2025, compared to a loss of 129 million yuan in the previous year [3] Group 2 - Guochuang High-tech forecasts a net profit of 16 million to 24 million yuan for 2025, recovering from a loss of 58.52 million yuan in the previous year [4] - Shiyi Da anticipates a net profit increase of 31 million to 46 million yuan for 2025, turning around from a loss of 23.41 million yuan last year [5] - Lijun Co. expects a net profit of 48 million to 66 million yuan for 2025, representing a decline of 45.05% to 60.03% compared to the previous year [7] Group 3 - Xindian Pharmaceutical plans to repurchase shares worth 25 million to 50 million yuan for employee stock ownership plans or equity incentives, with a maximum repurchase price of 42 yuan per share [6] - Jingchen Co. has set the initial transfer price for its shares at 82.85 yuan per share, with a total of 13.1 million shares to be transferred to 28 institutional investors [8] - Zejing Pharmaceutical received approval for clinical trials of its innovative cancer immunotherapy drug ZG005 in combination with platinum-based chemotherapy for advanced nasopharyngeal and esophageal squamous cell carcinoma [9] Group 4 - Xingqi Eye Medicine expects a net profit of 662 million to 749 million yuan for 2025, marking a growth of 95.82% to 121.56% compared to the previous year [10] - Liancheng Precision anticipates a net loss of 12 million to 17 million yuan for 2025, reducing its loss from 37.96 million yuan in the previous year [11] - Beidou Star expects a net loss of 230 million to 290 million yuan for 2025, improving from a loss of 350 million yuan last year [13] Group 5 - Qing Shan Paper's affiliate won a bid for a wastewater treatment project worth 51.9 million yuan [15] - Yiling Pharmaceutical forecasts a net profit of 1.2 billion to 1.3 billion yuan for 2025, recovering from a loss of 725 million yuan in the previous year [16] - Huahai Pharmaceutical received a drug registration certificate for its product used in treating depression and obsessive-compulsive disorder [23] Group 6 - Nanjing Panda expects a net profit of 10 million to 15 million yuan for 2025, turning around from a loss of 189 million yuan last year [40] - Rui Sheng Intelligent anticipates a net profit of 33.92 million to 38.40 million yuan for 2025, representing a growth of 112% to 140% compared to the previous year [41] - Jiechang Drive expects a net profit of 395 million to 437 million yuan for 2025, with a growth of 40% to 55% compared to the previous year [43]

金陵饭店（601007）(601007.SH)发布2025年度业绩预增公告，预计2025年度实现归属于母公司所有者 的净利润为5500万元到6350万元，与上年相比，将增加2174万元到3024万元，同比增长65.37%到 90.93%。 本期业绩预增主要原因系上年子公司北京金陵饭店有限公司终止经营事项拉低业绩基数，以及公司轻资 产酒店管理业务稳步增长等原因所致。 ...

智通财经APP讯，金陵饭店(601007.SH)发布2025年度业绩预增公告，预计2025年度实现归属于母公司 所有者的净利润为5500万元到6350万元，与上年相比，将增加2174万元到3024万元，同比增长65.37% 到90.93%。 本期业绩预增主要原因系上年子公司北京金陵饭店有限公司终止经营事项拉低业绩基数，以及公司轻资 产酒店管理业务稳步增长等原因所致。 ...